ChromaDex Granted U.S. Patent Number 10,000,520 C1 Covering The Composition Of Matter For The Disodium Salt Of NMNH
Portfolio Pulse from Benzinga Newsdesk
ChromaDex has been granted a U.S. patent for the composition of matter for the disodium salt of NMNH, which could enhance its intellectual property portfolio and potentially impact its market position.

August 19, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ChromaDex has received a U.S. patent for the disodium salt of NMNH, which could strengthen its intellectual property and market position.
The granting of a patent can enhance ChromaDex's competitive edge by protecting its innovations, potentially leading to increased market share and revenue. This news is likely to positively impact the stock price in the short term as it strengthens the company's intellectual property portfolio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100